University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Sarah T. Arron, Ph.D., M.D.

Dermatologic surgeon

Dr. Sarah Arron, a dermatologic surgeon, is director of the High Risk Skin Cancer Program, which cares for patients who are at risk for skin cancer due to organ transplant, leukemia, lymphoma or genetic syndromes. She specializes in an advanced procedure called Mohs micrographic surgery to treat certain types of skin cancer. Arron also is an expert in facial reconstruction following surgery, laser surgery, dermatology for organ transplant recipients and for those with genetic risk factors for skin cancer. In addition, she performs cosmetic procedures including Botox and soft tissue fillers.

Arron's research interests include studying skin cancer, particularly in patients who are immunosuppressed. She earned a medical degree at Weill Medical College of Cornell University and a doctorate at The Rockefeller University. She completed a residency in dermatology and a fellowship in Mohs micrographic surgery and procedural dermatology at UCSF. Arron is an assistant professor in residence of dermatology at UCSF and the Helen Diller Family Comprehensive Cancer Center.

Conditions & Treatments

Clinics

Dermatologic Surgery and Laser Center
1701 Divisadero St.
San Francisco, CA 94115
Phone: (415) 353–7878
Fax: (415) 353–7838

Hours: Monday to Friday, 8 a.m. – 5 p.m.

High Risk Skin Cancer Clinic
1701 Divisadero St., Third Floor
San Francisco, CA 94143-0316
Phone: (415) 353-7830
Fax: (415) 353-7860

Hours: Friday by appointment

Melanoma Center
1600 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Sarah T. Arron

Education

Cornell University School of Medicine 2003

Residencies

UCSF Medical Center, Dermatology 2008

Fellowships

UCSF Medical Center, Procedural Dermatology 2007

Selected Research and Publications

  1. Dybbro E, Mihalis E, Hirose R, Arron ST. Validity of patient skin cancer report among organ transplant recipients. Clin Transplant. 2012 Mar; 26(2):E132-6.
  2. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, North JP, Vemula SS, Mauro TM, Neuhaus IM, Leboit PE, Hur JS, Park K, Huh N, Kwok PY, Arron ST, Massion PP, Bale AE, Haussler D, Cleaver JE, Gray JW, Spellman PT, South AP, Aster JC, Blacklow SC, Cho RJ. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011 Oct 25; 108(43):17761-6.
  3. Arron ST, Skewes-Cox P, Do PH, Dybbro E, Da Costa M, Palefsky JM, Derisi JL. Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes. J Nucleic Acids. 2011; 2011:756905.
  4. Arron ST, Ruby JG, Dybbro E, Ganem D, Derisi JL. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol. 2011 Aug; 131(8):1745-53.
  5. Ibrahim SF, Singer JP, Arron ST. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg. 2010 Nov; 36(11):1752-5.
  6. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 2010 Feb 17; 17(2):135-47.
  7. Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS, Turner ML, Fox LP. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol. 2010 Jan; 62(1):31-7.
  8. Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol. 2007 Sep; 6(3):167-71.
  9. Arron ST, Liao W, Maurer T. Scurvy: a presenting sign of psychosis. J Am Acad Dermatol. 2007 Aug; 57(2 Suppl):S8-10.
  10. Arron ST, Kashani-Sabet M. Diagnosis of lymphoma in the draining lymph node basin at the time of in-transit metastasis of cutaneous melanoma. J Am Acad Dermatol. 2006 Jun; 54(6):1088-90.
  11. Arron ST, Ribeiro RM, Gettie A, Bohm R, Blanchard J, Yu J, Perelson AS, Ho DD, Zhang L. Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. Eur J Immunol. 2005 Jan; 35(1):46-55.
  12. Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S, Vesanen M, Spiegel H, Kost R, van Lunzen J, Stellbrink HJ, Wolinsky S, Borkowsky W, Palumbo P, Kostrikis LG, Ho DD. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med. 1999 Sep 6; 190(5):725-32.
  13. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999 Mar 15; 189(6):991-8.
  14. Zhang L, Huang Y, Yuan H, Tuttleton S, Ho DD. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology. 1997 Feb 17; 228(2):340-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.